Depreciation of Enveric Biosciences, Inc. from 31 Mar 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Enveric Biosciences, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2014 to 30 Sep 2025.
  • Enveric Biosciences, Inc. Depreciation for the quarter ending 30 Sep 2025 was $40,369, a 5.3% decline year-over-year.
  • Enveric Biosciences, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $159,494, a 6.7% decline year-over-year.
  • Enveric Biosciences, Inc. annual Depreciation for 2024 was $168,739, a 3.7% decline from 2023.
  • Enveric Biosciences, Inc. annual Depreciation for 2023 was $175,228, a 10% increase from 2022.
  • Enveric Biosciences, Inc. annual Depreciation for 2022 was $159,160, a 1096% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Enveric Biosciences, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $159,494 $40,369 -$2,257 -5.3% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $161,751 $39,982 -$2,609 -6.1% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $164,360 $38,842 -$4,379 -10% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $168,739 $40,301 -$2,193 -5.2% 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q3 2024 $170,932 $42,626 -$1,479 -3.4% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $172,411 $42,591 -$1,740 -3.9% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $174,151 $43,221 -$1,077 -2.4% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $175,228 $42,494 -$1,816 -4.1% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $177,044 $44,105 -$353 -0.79% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $177,397 $44,331 +$1,016 +2.3% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $176,381 $44,298 +$17,221 +64% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $159,160 $44,310 01 Oct 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $44,458 +$42,218 +1885% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $43,315 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $27,077 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 $2,240 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q1 2016 $111,628 +$103,285 +1238% 01 Jan 2016 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q1 2015 $8,343 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1

Enveric Biosciences, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $168,739 -$6,489 -3.7% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $175,228 +$16,068 +10% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $159,160 +$145,850 +1096% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 $13,310 01 Jan 2021 31 Dec 2021 10-K/A 09 Jun 2023 2022 FY
2016 $1,361,169 +$1,194,885 +719% 01 Jan 2016 31 Dec 2016 10-K/A 04 Apr 2017 2016 FY
2015 $166,284 +$132,912 +398% 01 Jan 2015 31 Dec 2015 10-K/A 04 Apr 2017 2016 FY
2014 $33,372 +$33,256 +28669% 01 Apr 2014 31 Mar 2015 10-KT 15 Mar 2016 2015 T3
2013 $116 01 Apr 2013 31 Mar 2014 10-KT 15 Mar 2016 2015 T3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.